Humam Kadara

10.4k citations

95 papers · 3.2k indexed · h-index 34

Molecular Biology top 5%
Oncology top 2%
Pulmonary and Respiratory Medicine top 2%
Cancer Research top 2%
Immunology top 5%

Co-authors: Ignacio I. Wistuba Carmen Behrens Reuben Lotan J. Jack Lee Dafna Lotan Junya Fujimoto Luisa M. Solis Zahraa Rahal
Topics: Lung Cancer Treatments and Mutations (31 papers)Cancer Genomics and Diagnostics (24 papers)RNA modifications and cancer (19 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Investigation Nature Communications Journal of Clinical Oncology
Partner nations: United States Lebanon Japan

In The Last Decade

Humam Kadara

91 papers receiving 3.2k citations

Peers

Countries citing papers authored by Humam Kadara

Since Specialization

Citations

This map shows the geographic impact of Humam Kadara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Humam Kadara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Humam Kadara more than expected).

Fields of papers citing papers by Humam Kadara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Humam Kadara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Humam Kadara. The network helps show where Humam Kadara may publish in the future.

Co-authorship network of co-authors of Humam Kadara

This figure shows the co-authorship network connecting the top 25 collaborators of Humam Kadara. A scholar is included among the top collaborators of Humam Kadara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Humam Kadara. Humam Kadara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumour and microenvironment crosstalk in NSCLC progression and response to therapy 2025 ·Nature Reviews Clinical Oncology ·Zahraa Rahal,(unknown),Seyed Javad Moghaddam,Tina Cascone,Humam Kadara	7
2	Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer 2022 ·JCI Insight ·Bo Yuan,(unknown),(unknown),(unknown),Qian Peng,Yewen Shi,(unknown),(unknown),Shuanying Yang,(unknown),Seon Hee Chang,John V. Heymach,Jianjun Zhang,Edwin J. Ostrin,Stephanie S. Watowich,Humam Kadara,Seyed Javad Moghaddam	43
3	Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro Models 2020 ·Molecules ·(unknown),(unknown),(unknown),Ansam Sinjab,Humam Kadara,Wassim Abou‐Kheir,(unknown)	11
4	Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On? 2020 ·Cancer Research ·Ansam Sinjab,Guangchun Han,Linghua Wang,Humam Kadara	15
5	IL22 Promotes Kras -Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties 2018 ·Cancer Immunology Research ·Nasim Khosravi,Mauricio S. Caetano,Amber M. Cumpian,Neşe Ünver,Cynthia De la Garza‐Ramos,(unknown),(unknown),Belinda Hernández,(unknown),Scott E. Evans,Samir Hanash,Andrei M. Alekseev,Yi Yang,Seon Hee Chang,Roza Nurieva,Humam Kadara,Jichao Chen,Edwin J. Ostrin,Seyed Javad Moghaddam	49
6	Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma 2018 ·Cancer Prevention Research ·Jacob Kantrowitz,Ansam Sinjab,Xu Li,(unknown),Smruthy Sivakumar,Wenhua Lang,(unknown),Junya Fukuoka,Georges Nemer,Nadine Darwiche,Hassan Chami,Arafat Tfayli,Ignacio I. Wistuba,Paul Scheet,Junya Fujimoto,Avrum Spira,Humam Kadara	15
7	Genomics of adult and pediatric solid tumors. 2018 ·Europe PMC (PubMed Central) ·Zahraa Rahal,(unknown),Humam Kadara,Raya Saab	33
8	Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma 2017 ·Cancer ·Frederico O. Gleber‐Netto,Mei Zhao,Sanchit Trivedi,Jiping Wang,Samar A. Jasser,(unknown),Humam Kadara,Jiexin Zhang,Jing Wang,William N. William,J. Jack Lee,Minh Ly Nguyen,Sara I. Pai,Heather M. Walline,Dong M. Shin,Robert L. Ferris,Thomas E. Carey,Jeffrey N. Myers,Curtis R. Pickering	18
9	Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients 2016 ·Clinical Cancer Research ·Edwin R. Parra,Carmen Behrens,Jaime Rodriguez‐Canales,Heather Lin,Barbara Mino,Jorge Blando,Jianjun Zhang,Don L. Gibbons,John V. Heymach,Boris Sepesi,Stephen G. Swisher,Annikka Weissferdt,Neda Kalhor,Julie Izzo,Humam Kadara,César A. Moran,J. Jack Lee,Ignacio I. Wistuba	103
10	IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer 2016 ·Cancer Research ·Mauricio S. Caetano,Huiyuan Zhang,Amber M. Cumpian,Lei Gong,Neşe Ünver,Edwin J. Ostrin,(unknown),Seon Hee Chang,Cesar E. Ochoa,Samir Hanash,Carmen Behrens,Ignacio I. Wistuba,Cinthya Sternberg,Humam Kadara,Carlos Gil Ferreira,Stephanie S. Watowich,Seyed Javad Moghaddam	169
11	ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer 2013 ·Clinical Cancer Research ·Mohamed Kabbout,Melinda Garcia,Junya Fujimoto,Diane D. Liu,Denise M. Woods,Chi‐Wan Chow,Gabriela Mendoza,Amin A. Momin,Brian P. James,Luisa M. Solis,Carmen Behrens,J. Jack Lee,Ignacio I. Wistuba,Humam Kadara	116
12	Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy 2013 ·Clinical Cancer Research ·Kathryn A. Gold,Edward S. Kim,Diane D. Liu,Ping Yuan,Carmen Behrens,Luisa M. Solis,Humam Kadara,David C. Rice,Ignacio I. Wistuba,Stephen G. Swisher,Wayne L. Hofstetter,J. Jack Lee,Waun Ki Hong	27
13	EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma 2013 ·Clinical Cancer Research ·Carmen Behrens,Luisa M. Solis,Heather Lin,Ping Yuan,Ximing Tang,Humam Kadara,Erick Riquelme,Héctor Galindo,César A. Moran,Neda Kalhor,Stephen G. Swisher,George R. Simon,David J. Stewart,J. Jack Lee,Ignacio I. Wistuba	123
14	Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling 2012 ·Cancer Prevention Research ·Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi‐Wan Chow,Wenhua Lang,(unknown),Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,(unknown),Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba	26
15	Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis 2011 ·Clinical Cancer Research ·Ximing Tang,Humam Kadara,Carmen Behrens,Diane D. Liu,Yun Xiao,David C. Rice,Adi F. Gazdar,Junya Fujimoto,César A. Moran,Marileila Varella‐Garcia,J. Jack Lee,Waun Ki Hong,Ignacio I. Wistuba	59
16	A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis 2010 ·Clinical Cancer Research ·Humam Kadara,Carmen Behrens,Ping Yuan,Luisa M. Solis,Diane Liu,Xuemin Gu,John D. Minna,J. Jack Lee,Edward Kim,(unknown),Ignacio I. Wistuba,Reuben Lotan	68
17	Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor 2010 ·Cancer Research ·Yulong Chen,Jiong Deng,Junya Fujimoto,Humam Kadara,Taoyan Men,Dafna Lotan,Reuben Lotan	44
18	Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis 2010 ·Cancer Prevention Research ·Jiong Deng,Junya Fujimoto,(unknown),(unknown),Carolyn S. Van Pelt,(unknown),(unknown),Humam Kadara,(unknown),Dafna Lotan,Reuben Lotan	65
19	Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System 2009 ·Cancer Prevention Research ·Humam Kadara,Ludovic Lacroix,Carmen Behrens,Luisa M. Solis,Xuemin Gu,J. Jack Lee,E Tahara,Dafna Lotan,Waun Ki Hong,Ignacio I. Wistuba,Reuben Lotan	49
20	Expression of Interleukin-1 Receptor–Associated Kinase-1 in Non–Small Cell Lung Carcinoma and Preneoplastic Lesions 2009 ·Clinical Cancer Research ·Carmen Behrens,Lei Feng,Humam Kadara,Hyun Jung Kim,J. Jack Lee,Reza J. Mehran,Waun Ki Hong,Reuben Lotan,Ignacio I. Wistuba	33

About Humam Kadara

Humam Kadara is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Cancer Genomics and Diagnostics (24 papers) and RNA modifications and cancer (19 papers). The work is most often cited by research in Cancer Research (900 citations), Oncology (1.1k citations) and Pulmonary and Respiratory Medicine (914 citations). Humam Kadara has collaborated with scholars based in United States, Lebanon and Japan. Frequent co-authors include Ignacio I. Wistuba, Carmen Behrens, Reuben Lotan, J. Jack Lee, Dafna Lotan, Junya Fujimoto, Luisa M. Solis, Zahraa Rahal, Ansam Sinjab and Raya Saab. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact